Grzegorz Nowakowski, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    MorphoSys AG
    Date added:
    09/29/2023
    Date updated:
    09/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech Inc
    Date added:
    09/29/2023
    Date updated:
    09/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Curis
    Date added:
    09/29/2023
    Date updated:
    09/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Seagen
    Date added:
    09/29/2023
    Date updated:
    09/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol-Myers Squibb
    Date added:
    09/29/2023
    Date updated:
    09/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    F Hoffmann-La Roche Limited
    Date added:
    09/29/2023
    Date updated:
    09/29/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Constellation Pharmaceuticals
    Date added:
    09/29/2023
    Date updated:
    09/29/2023

Pages

Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes